Last $15.13 USD
Change Today +0.03 / 0.20%
Volume 695.5K
AUXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan J. Wills

Executive Vice President of Corporate Development, Auxilium Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$1,208,359
As of Fiscal Year 2012

Background*

Mr. Alan Wills has been Executive Vice President of Corporate Development at Auxilium Pharmaceuticals Inc. since October 2010. Mr. Wills joined Auxilium in October 2010 as Executive Vice President, Corporate Development. Since August 2009, he served as Vice President, Worldwide Strategy at Pfizer, Inc., where he had been responsible for corporate strategic planning and other cross-business unit strategic initiatives. He served as Vice President of Corporate Strategy ...

Read Full Background

Corporate Headquarters*

640 Lee Road
Malvern, Pennsylvania 19087

United States

Phone: 484-321-5900
Fax: 484-321-5999

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Harvard Business School
Bachelor's Degree
University of Oxford

Other Affiliations*

Annual Compensation*

Salary$352,500
Bonus$25,000
Total Annual Compensation$377,500

Stock Options*

Restricted Stock Awards$129,407
All Other Compensation$19,399
Exercisable Options47,500
Unexercisable Options124,500
Total Number of Options172,000

Total Compensation*

Total Annual Cash Compensation$532,049
Total Short Term Compensation$377,500
Other Long Term Compensation$148,806
Total Calculated Compensation$1,208,359
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AUXL:US $15.13 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul M. Bisaro Chief Executive Officer, President and Director
Actavis, Inc.
$2.4M
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$998.1K
Jeremy Levin D.Phil., MB, B.ChirChief Executive Officer and President
Teva Pharmaceutical Industries Limited
--
Paul K. Wotton Ph.D.Chief Executive Officer, President and Director
Antares Pharma Inc.
$477.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AUXILIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.